Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 7 min ago

Sigmoid Pharma Announces Acquisition of Freund Pharmatec Ltd.

Thu, 02/04/2016 - 15:15
DUBLIN, Ireland, Feb. 04, 2016 -- (Healthcare Sales & Marketing Network) -- SIGMOID PHARMA LIMITED, a privately-owned, specialty pharmaceutical company developing innovative therapeutics for gastrointestinal and immunological diseases using its proprietary...
Biopharmaceuticals, Drug Delivery, Mergers & Acquisitions
Sigmoid Pharma, Freund Pharmatec, SmPill, Single-Multiple Pill

Cerapedics Announces Publication of Results from Pivotal IDE Clinical Trial of i-FACTOR(TM) Bone Graft in the Cervical Spine

Thu, 02/04/2016 - 15:12
Results published in peer-reviewed journal Spine show peptide enhanced bone graft is safe and effective when compared to local autograft in ACDF procedures WESTMINSTER, Colo., Feb. 4, 2016 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a priv...
Devices, Orthopaedic, Neurosurgery
Cerapedics, Bone Graft, orthobiologic

Medovex Receives Reimbursement for Its DenerveX Facet Joint Syndrome Treatment in Germany

Thu, 02/04/2016 - 15:08
ATLANTA, GA--(Healthcare Sales & Marketing Network) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that the reimbursement authority in Germany has released new reimbursement payment coding for the DenerveX™ Syst...
Devices, Orthopaedic, Neurosurgery, Reimbursement
Medovex, DenerveX, Facet Joint Syndrome

GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy

Thu, 02/04/2016 - 13:39
Company's Proprietary Genomic Classifier Demonstrates Unprecedented Accuracy in Diagnostic Biopsies Study Published in Urology SAN DIEGO, Feb. 4, 2016 -- (Healthcare Sales & Marketing Network) -- GenomeDx Biosciences today announced publication of res...
Diagnostics, Oncology
GenomeDx Biosciences, Decipher Prostate, Cancer Classifier

Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer

Thu, 02/04/2016 - 13:32
NEW YORK, NY--(Healthcare Sales & Marketing Network) - Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced the appointment of Steven A. Fi...
Biopharmaceuticals, Oncology, Personnel
Lion Biotechnologies, immunotherapies

Eagle Pharmaceuticals Announces Appointment of Michael Moran as U.S. Head of Sales

Thu, 02/04/2016 - 13:27
WOODCLIFF LAKE, N.J.--(Healthcare Sales & Marketing Network)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (EGRX) today announced that it has appointed Michael Moran, a seasoned sales executive in the pharmaceuticals industry, to the role of U.S....
Biopharmaceuticals, Personnel
Eagle Pharmaceuticals

CollPlant Reports Positive Final Trial Results for Vergenix(TM)STR, Indicated for the Treatment of Tendinopathy

Thu, 02/04/2016 - 13:20
Clinical Success Demonstrated, with Improvement in Pain and Functionality at Three and Six-month Follow-ups NESS ZIONA, Israel, February 4, 2016 -- (Healthcare Sales & Marketing Network) -- CollPlant Ltd. (CLPT.TA), a regenerative medicine company util...
Biopharmaceuticals, Regenerative Medicine
CollPlant, rhCollagen, VergenixSTR, tendinopathy

Silk Therapeutics Raises $6 Million In Series A2 Financing

Wed, 02/03/2016 - 19:34
Innovative Biotech Company Focused on Natural Silk Protein Raises $10.25 Million in Funding To Date MEDFORD, Mass., Feb. 3, 2016 -- (Healthcare Sales & Marketing Network) -- Silk Therapeutics, Inc., today announced the closing of a $6 million Series A2...
Dermatology, Venture Capital
Silk Therapeutics, silk protein solutions

TapImmune Granted Fast Track Designation by U.S. Food and Drug Administration for its Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer

Wed, 02/03/2016 - 18:00
Expedites TapImmune's clinical development program for ovarian cancer Follows recent Orphan Drug Designation for TPIV 200 in the same indicatio JACKSONVILLE, Florida, February 3, 2016 -- (Healthcare Sales & Marketing Network) -- TapImmune, Inc. (TPI...
Biopharmaceuticals, Oncology, FDA
TapImmune, immunotherapy, Ovarian Cancer, cancer vaccine

BioDirection, Inc. Closes $4 Million Series B Financing

Wed, 02/03/2016 - 17:57
Financing to support final stages of development program for Tbit™ (traumatic brain injury test) technology, designed to aid in diagnosis of concussions and other brain injuries in less than 90-seconds at point-of-care BOSTON, Feb. 3, 2016 -- (Healthcar...
Devices, Diagnostics, Neurology, Venture Capital
BioDirection, Tbit, traumatic brain injury

Maquet Medical Systems USA, A Getinge Group Company Announces Partnership with BIOTRONIK to Distribute Endovascular Medical Devices in United States

Wed, 02/03/2016 - 14:28
WAYNE, N.J., Feb. 3, 2016 -- (Healthcare Sales & Marketing Network) -- Maquet Medical Systems USA, a Getinge Group Company announced today that it has entered into a partnership with BIOTRONIK, a Berlin, Germany-based manufacturer of cardiovascular and en...
Devices, Interventional, Distribution
Maquet Medical Systems, Getinge Group, BIOTRONIK

Emmaus Life Sciences Announces Management Promotions

Wed, 02/03/2016 - 14:24
TORRANCE, Calif., Feb. 3, 2016 -- (Healthcare Sales & Marketing Network) -- Emmaus Life Sciences, Inc. (the Company or Emmaus), a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies ...
Biopharmaceuticals, Personnel
Emmaus Life Sciences, Sickle Cell Disease

ProtoStar(TM) Announces the LifeWalker(TM) Upright, a New Medical Walker Designed to Enable Users to Stand Upright and Walk Safer and Longer for Improved Health

Wed, 02/03/2016 - 14:18
SAN DIEGO, Feb. 3, 2016 -- (Healthcare Sales & Marketing Network) -- ProtoStar™, Inc., a designer and developer of advanced medical assistive mobility devices, announced today the launch of the LifeWalker™ Upright, a next-generation medical walker designe...
Devices, Product Launch
ProtoStar, LifeWalker Upright

ProMIS Neurosciences announces identification of a second novel therapeutic target for Alzheimer's disease

Wed, 02/03/2016 - 14:11
Novel target is second in a series of potential targets on strains of misfolded Amyloid beta, implicated in the development and progression of Alzheimer's TORONTO, Feb. 3, 2016 (Healthcare Sales & Marketing Network) - ProMIS Neurosciences is currently i...
Biopharmaceuticals, Neurology
ProMIS Neurosciences, misfolded Amyloid beta, Alzheimer's disease

LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer

Wed, 02/03/2016 - 13:29
Bringing the Total Raised for the Current Class of 4Catalyzer Companies to a Quarter-Billion Dollars GUILFORD, CT--(Healthcare Sales & Marketing Network) - LAM Therapeutics closed a $40 million financing to accelerate the development of therapeutics for...
Biopharmaceuticals, Oncology, Venture Capital
LAM Therapeutics, lymphangioleiomyomatosis, lymphoma

First Patient Treated With LC Bead LUMI(TM) Radiopaque Embolic Bead Supported by Philips Live Image Guidance

Wed, 02/03/2016 - 13:21
Collaboration brings new tools to interventional radiologists and oncologists to help treat liver cancer and enhanced patient care LONDON, February 3, 2016 -- (Healthcare Sales & Marketing Network) -- BTG plc (BTG.L), a global specialist healthcare com...
Devices, Interventional, Oncology, Radiology
BTG plc, Philips, LC Bead LUMI, liver cancer, embolic beads

Telesta Therapeutics Receives Complete Response Letter from FDA

Tue, 02/02/2016 - 19:52
MONTREAL, Feb. 2, 2016 -- (Healthcare Sales & Marketing Network) - Telesta Therapeutics Inc. (TST.TO) (BNHLF) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter to Telesta's Biologics License Applicatio...
Biopharmaceuticals, Oncology, FDA
Telesta Therapeutics, MCNA, bladder cancer

Potrero Medical Commences NIH-backed PRESCIENT Study of Accuryn(TM) For Early Detection of Critical Illness

Tue, 02/02/2016 - 18:13
SAN FRANCISCO, Feb. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Potrero Medical, Inc. today announced the start of the PRESCIENT study, an NIH-sponsored, multi-center observational study using the Accuryn™ Monitoring System to detect the physiolo...
Devices, Monitoring
Potrero Medical, Accuryn Monitoring System, sepsis

Lupin Launches Generic Glumetza(R) HCI ER Tablets in the US

Tue, 02/02/2016 - 15:27
MUMBAI and BALTIMORE, February 2, 2016 -- (Healthcare Sales & Marketing Network) -- Pharma Major Lupin Limited (Lupin) announced today that its US subsidiary, Lupin Pharmaceuticals Inc., has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to mar...
Biopharmaceuticals, Generics, Endocrinology, Product Launch
Lupin, Metformin, Glumetza, diabetes

Spero Therapeutics Announces $30 Million Series B Preferred Financing

Tue, 02/02/2016 - 15:23
Funding Supports Development of Novel Therapies To Treat Gram-Negative Bacterial Infections CAMBRIDGE, Mass., Feb. 2, 2016 -- (Healthcare Sales & Marketing Network) -- Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies t...
Biopharmaceuticals, Venture Capital
Spero Therapeutics, Potentiator

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong